JP2008509914A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509914A5
JP2008509914A5 JP2007525753A JP2007525753A JP2008509914A5 JP 2008509914 A5 JP2008509914 A5 JP 2008509914A5 JP 2007525753 A JP2007525753 A JP 2007525753A JP 2007525753 A JP2007525753 A JP 2007525753A JP 2008509914 A5 JP2008509914 A5 JP 2008509914A5
Authority
JP
Japan
Prior art keywords
acid
salt
diphenylbarbituric
diphenylbarbituric acid
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2007525753A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509914A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/028380 external-priority patent/WO2006026095A2/en
Publication of JP2008509914A publication Critical patent/JP2008509914A/ja
Publication of JP2008509914A5 publication Critical patent/JP2008509914A5/ja
Ceased legal-status Critical Current

Links

JP2007525753A 2004-08-10 2005-08-10 ５，５−ジフェニルバルビツル酸の改良されたバイオアベイラビリティ及び高められた脳送達のための組成物及び方法 Ceased JP2008509914A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60032704P 2004-08-10 2004-08-10
PCT/US2005/028380 WO2006026095A2 (en) 2004-08-10 2005-08-10 Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013118224A Division JP2013177442A (ja) 2004-08-10 2013-06-04 ５，５−ジフェニルバルビツル酸の改良されたバイオアベイラビリティ及び高められた脳送達のための組成物及び方法

Publications (2)

Publication Number Publication Date
JP2008509914A JP2008509914A (ja) 2008-04-03
JP2008509914A5 true JP2008509914A5 (enExample) 2008-09-25

Family

ID=34942111

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007525753A Ceased JP2008509914A (ja) 2004-08-10 2005-08-10 ５，５−ジフェニルバルビツル酸の改良されたバイオアベイラビリティ及び高められた脳送達のための組成物及び方法
JP2013118224A Pending JP2013177442A (ja) 2004-08-10 2013-06-04 ５，５−ジフェニルバルビツル酸の改良されたバイオアベイラビリティ及び高められた脳送達のための組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013118224A Pending JP2013177442A (ja) 2004-08-10 2013-06-04 ５，５−ジフェニルバルビツル酸の改良されたバイオアベイラビリティ及び高められた脳送達のための組成物及び方法

Country Status (14)

Country Link
EP (2) EP1625848A1 (enExample)
JP (2) JP2008509914A (enExample)
KR (2) KR20070074549A (enExample)
CN (2) CN102512422A (enExample)
AT (1) ATE510541T1 (enExample)
AU (1) AU2005280419B2 (enExample)
BR (1) BRPI0513337A (enExample)
CA (1) CA2576832C (enExample)
IL (1) IL181247A (enExample)
MX (1) MX2007001655A (enExample)
NZ (1) NZ553653A (enExample)
SG (1) SG163500A1 (enExample)
WO (1) WO2006026095A2 (enExample)
ZA (1) ZA201106419B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756379B2 (en) 2001-07-26 2004-06-29 Taro Pharmaceutical Industries Ltd. Non-sedating barbiturate compounds as neuroprotective agents
US7683071B2 (en) 2000-07-26 2010-03-23 Taro Pharmaceuticals Industries Ltd. Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid
CN100502871C (zh) 2002-12-11 2009-06-24 塔罗制药工业有限公司 巴比土酸衍生物在制备用于治疗运动障碍的药物中的应用
EP1625848A1 (en) * 2004-08-10 2006-02-15 Taro Pharmaceuticals North America, Inc. Composition and method for enhanced delivery of 5,5-diphenyl barbituric acid
CN102863579B (zh) * 2012-09-14 2014-02-05 东南大学 一种巴比妥酸螯合树脂及其制备方法和应用
KR102162003B1 (ko) 2014-04-14 2020-10-06 삼성전자주식회사 무선 네트워크 연결 제어 방법 및 장치
KR101822417B1 (ko) * 2017-06-14 2018-01-29 주식회사 청도제약 인간의 체액에서 산화 스트레스를 측정하기 위한 방법
GB202100352D0 (en) * 2021-01-12 2021-02-24 Balticgruppen Bio Ab New methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2119701A (en) * 1934-06-29 1938-06-07 Winthrop Chem Co Inc Alkoxyalkyl mercury nitrogen compounds
IL69722A (en) * 1983-09-14 1986-09-30 Taro Pharma Ind Oxopyrimidine derivatives and pharmaceutical compositions containing them
DE4433764A1 (de) * 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
US6093820A (en) * 1997-10-02 2000-07-25 Taro Pharmaceutical Industries Ltd. Method and reagents for N-alkylating ureides
US6756379B2 (en) * 2001-07-26 2004-06-29 Taro Pharmaceutical Industries Ltd. Non-sedating barbiturate compounds as neuroprotective agents
EP1311270B1 (en) * 2000-07-26 2008-01-09 Taro Pharmaceutical Industries Limited Non-sedating barbiturate compounds as neuroprotective agents
CN1896084A (zh) * 2002-01-30 2007-01-17 塔罗制药工业有限公司 非镇静性巴比土酸衍生物
CN100502871C (zh) * 2002-12-11 2009-06-24 塔罗制药工业有限公司 巴比土酸衍生物在制备用于治疗运动障碍的药物中的应用
EP1625848A1 (en) * 2004-08-10 2006-02-15 Taro Pharmaceuticals North America, Inc. Composition and method for enhanced delivery of 5,5-diphenyl barbituric acid

Similar Documents

Publication Publication Date Title
EP2573070B1 (en) Crystal form of (s)-4-hydroxy-2-oxo-1-pyrrolidine acetamide, preparation method and use thereof
KR102275326B1 (ko) 야누스 키나제(jak) 억제제의 바이설페이트 및 그의 제조 방법
US20070264330A1 (en) Pharmaceutical formulations of pimavanserin
EP1622586B1 (en) Process for preparing tannate tablet capsule or other solid dosage forms
CN104603123A (zh) 曲格列汀的固态形式及其制备方法和用途
CA2662265A1 (en) Imatinib compositions
KR20100033377A (ko) 아타자나비르를 함유하는 정제 조성물
JP2008509914A5 (enExample)
MX2007008724A (es) Complejo metalico de tetraciclina en una forma de dosificacion solida.
JP7403647B2 (ja) レバムロジピンベシル酸塩水和物含有組成物及びその調製方法
KR20140111044A (ko) 구연산아일데나필 결정 형태 o 및 그의 제조방법과 용도
US9670156B2 (en) Crystal form III of (S)-oxiracetam, preparation method and use thereof
CZ302924B6 (cs) Farmaceutický prostredek obsahující jako aktivní složku derivát benzamidu
KR20190010578A (ko) 새로운 다파글리플로진 결정형 및 그의 제조 방법 및 용도
US20150087686A1 (en) Crystalline forms of saxagliptin
KR101121589B1 (ko) 안정성이 향상된 무정형 아데포비어 디피복실 고체분산체 및 이의 제조방법
KR102170422B1 (ko) 토파시티닙의 신규 염, 이의 제조방법 및 이를 포함하는 약학 조성물
KR20090013736A (ko) 메트포르민 산 부가염을 포함하는 서방성 제제
US7482486B2 (en) Methods for the preparation and formulation of magnesium valproate hydrate
KR102756994B1 (ko) 사쿠비트릴, 발사르탄, 및 니코틴아미드의 공동무정형
KR102728294B1 (ko) 흡습성이 개선된 글리세릴 포스포릴 콜린을 포함하는 고형 제제, 이의 용도 또는 제조방법
US20030022921A1 (en) Stable pharmaceutical formulation comprising torsemide modification II
KR20100091127A (ko) 아데포비어 디피복실의 신규한 염 및 그의 제조방법
CN1903869A (zh) 替比夫定的衍生物盐及其制备方法和药物应用
CN103126994A (zh) 含决奈达隆的固体药物组合物